Revenue | ₹1.95Cr |
Net Profits | ₹0.76Cr |
Net Profit Margins | -38.97% |
Parmax Pharma Ltd’s revenue fell -75.06% since last year same period to ₹1.95Cr in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated -58.77% fall in its revenue since last 3-months.
Parmax Pharma Ltd’s net profit fell -7700% since last year same period to ₹0.76Cr in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 48.99% jump in its net profits since last 3-months.
Parmax Pharma Ltd’s net profit margin fell -30577.95% since last year same period to -38.97% in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated -23.72% fall in its net profit margins since last 3-months.
The revenue for Parmax Pharma Ltd in the Q1 results 2025 was ₹1.95Cr.
The net profit for Parmax Pharma Ltd in the Q1 results 2025 was ₹0.76Cr.
The net profit margin for Parmax Pharma Ltd in the Q1 results 2025 was -38.97%.
The revenue for Parmax Pharma Ltd in the Q1 results 2024 was ₹7.82Cr.
The net profit for Parmax Pharma Ltd in the Q1 results 2024 was ₹0.01Cr.
The net profit margin for Parmax Pharma Ltd in the Q1 results 2024 was 0.13%.